Teva Pharmaceutical Industries reported $1.17B in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Aspen Pharmacare ZAR 444.02M 0 Jun/2026
Cipla INR 807.87M 88K Sep/2026
Dr.Reddys Laboratories INR 833.07M 382K Sep/2026
Guangzhou Baiy CNY 1.63B 0 Sep/2026
Jiangsu Hengrui CNY 6.64B 0 Sep/2026
Kalbe Farma IDR 45.19B 55.54M Sep/2026
Richter Gedeon HUF 183.08M 215.04K Jun/2026
Sh Fosun Pharma CNY 2.67B 0 Sep/2026
Sun Pharmaceuticals INR 2.4B 0 Sep/2026
Teva Pharmaceutical Industries USD 1.17B 2M Sep/2026